NAN Nanoscience

    Embargoed Release: 07:00 hrs Wednesday 3rd September 2008

                               Nanoscience Inc.                                

                  (`Nanoscience' or the `Company' or `Group')                  

          Notice of Extraordinary General Meeting and Change of Name           

Nanoscience, the specialist niche investor in emerging technologies with strong
commercial propositions for the healthcare and electronic sectors, is convening
an Extraordinary General Meeting ("EGM") at 12:00 CET 26 September 2008 at the
Zurich Marriott Hotel, Neumuhlequai 42, Zurich 8001, to consider resolutions to 
change the Company's name to Toumaz Holdings Inc. and an internal reorganisation 
of the administrative structure of the Company's business.

CHANGE OF NAME

Since the acquisition of Toumaz Technology Limited ("Toumaz") in November 2005,
the Company has become increasingly focused on the research and development
activities of Toumaz and the planning of the future commercialisation of its
technology. As such, the Directors of the Company believe that the proposed
change of name better reflects the Company's commercial priorities. In order to
action the change of name a special resolution must be passed at a general
meeting of the Company and consequently the EGM is being convened.

Following the re-registration of the Company's name, the Company's shares will
be traded on AIM under a new EPIC code, TMZ. The Company's website will change
to www.toumazholdings.com

INTERNAL REORGANISATION

The Directors of Nanoscience intend to restructure the Group into three
administrative areas:

1. the development of new technologies (which will continue to be undertaken
within Toumaz) and their commercialisation as they become mature;

2. the management of intellectual property rights created;

3. and the management of non-Toumaz related investments.

This will ensure the commercial focus of the Group maximises the future returns
the Directors believe are attainable from its asset base. In addition, the
global opportunity available to the business in its commercial expansion must
address the complexities of global tax and licensing as the move from research
towards development progresses and the anticipated rollout of products in 2009
unfolds. The proposed reorganisation will therefore consist of the following
actions (together "the Proposals"):

1. the transfer of such intellectual property rights as have been developed by
Toumaz to date to a newly formed and wholly owned company called Toumaz IP .
This company will also manage all new IP developed by Toumaz in the future; and

2. the transfer of the Group's non-Toumaz assets and investments to a newly
formed and wholly owned vehicle.

A circular convening an EGM to consider the change of name and internal
reorganisation has been posted to shareholders and the document is available to
download from the Company's website, www.nanosc.com

For further information please contact:

Guy Spelman              Nanoscience Inc.               Tel: +44 7767 338 967  
                                                                               
Sam Smith/               FinnCap                        Tel: 020 7600 1658     
                                                                               
Charles Cunningham                                                             
                                                                               
Vikki Krause             Hansard Group                  Tel: +44 207 245 1100  



END

Nanoscience (LSE:NAN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Nanoscience (LSE:NAN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024